Breaking News2 years ago
MEDSIR’s PHERGain Trial Shows Potential for Chemotherapy-free Treatment of HER2-positive Early Breast Cancer
[ad_1] Newswise — JERSEY CITY, N.J., June 2, 2023 /PRNewswire/ — MEDSIR announced today the positive results of the PHERGain trial. This study is the first to use an adaptive design...
